Hubert H. Chuang, M.D., Ph.D.
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, Diagnostic Radiology - The University of Texas Health Science Center at Houston, Houston
Professor, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Nuclear Medicine, Diagnostic Radiology - The University of Texas Health Science Center at Houston, Houston
Professor, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2002 | Washington University School of Medicine, St. Louis, Missouri, US, Immunology, Ph.D |
| 2002 | Washington University School of Medicine, St. Louis, Missouri, US, MD |
| 1992 | Yale University, New Haven, Connecticut, US, Molecular Biophysics and Biochemistry, BS |
Postgraduate Training
| 2007-2008 | Fellowship in PET/CT, Johns Hopkins University, Baltimore, Maryland |
| 2005-2007 | Residency in Nuclear Medicine, Montefiore Medical Center, Bronx, New York |
| 2002-2004 | Resident in Internal Medicine, Yale New Haven Hospital, New Haven, Connecticut |
Licenses & Certifications
| 2014 | Controlled Substance Registration Certificate (DEA) |
| 2009 | Certification Board of Nuclear Cardiology |
| 2008 | Texas Medical Board |
| 2007 | Medical Physician |
| 2007 | American Board of Nuclear Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022
Assistant Professor, Department of Nuclear Medicine, Diagnostic Radiology - The University of Texas Health Science Center at Houston, Houston, TX, 2010 - 2017
Assistant Professor, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2015
Administrative Appointments/Responsibilities
Rotation Site Director, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017
Extramural Institutional Committee Activities
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Institutional Review Board 5 (IRB 5), The University of Texas MD Anderson Cancer Center, 2013 - 2018
Member, DI Functional Educational Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2019
Associate Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Member, PET/CT QA & Education Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, The University of Texas MD Anderson Cancer Center, Houston, TX, Graduate Medical Education Budget Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Associate Member, Institutional Review Board 5 (IRB 5), The University of Texas MD Anderson Cancer Center, 2012 - 2013
Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Member, DI Radiologist IT Advisory Group, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, Nuclear Medicine Research Peer Review Committee, The University of Texas MD Anderson Cancer Center, 2008 - Present
Alternate Member, Credential Committee, The University of Texas MD Anderson Cancer Center
Editorial Activities
Associate Editor, Journal of Computer Assisted Tomography, 2021 - Present
Board Member, Journal of Computer Assisted Tomography, 2019 - Present
Honors & Awards
| 2008 | Best Clinical Paper - 2nd Place, Young Professionals Committee, SNM Annual Meeting |
| 2003 | AAAAI Allergic Skin Diseases Research Award, Fujisawa |
| 1996 | American Diabetes Association Medical Student Research Fellowship, 1996, American Diabetes Association |
| 1991 | Humana Foundation Scholarship, Humana Foundation |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Oncologic-Endocrinology Lecture Series. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2022. Medical Physics Graduate Program. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2021. Parathyroid SPECT/CT +4D Neck CT: Use of Intravenous Contrast. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2020. Nuclear Medicine Imaging in Thyroid Cancer (Cancelled due to COVID Pandemic). Conference. Department of Endocrine Neoplasia and Hormonal Directors. Houston, TX, US.
- 2017. FDG-PET/CT and Lymphoma: an insider's guide for clinicians. Conference. University of Texas Health Science Center. Houston, TX, US.
- 2016. FDG-PET/CT and Lymphoma: An Insider's Guide for Clinicians. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2015. Lymphoma Response Reporting 2015 Update. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. PET/CT in Lymphoma: An Insider's Guide for the Clinician. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. PET/CT Normal Variants and Pitfalls: The Chest. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2012. Imaging during Pregnancy. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2011. Incidental Findings on PET/CT - Head & Neck. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2010. PET and Lymphoma: An Update. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2021. Somatostatin PET/CT (Cancelled due to COVID Pandemic). Conference. Greater New York Chapter, Society of Nuclear Medicine Spring Symposium. Atlantic City, NJ, US.
- 2020. Somatostatin PET/CT (Cancelled due to COVID Pandemic). Conference. Greater New York Chapter, Society of Nuclear Medicine Spring Symposium. Atlantic City, NJ, US.
- 2019. Artifacts, Incidentals, and Pitfalls in PET/CT - Part 2: Abdomen & Pelvis, Musculoskeletal. Conference. Greater New York Chapter, Society of Nuclear Medicine Spring Symposium. Atlantic City, NJ, US.
- 2019. Artifacts, Incidentals, and Pitfalls in PET/CT. Conference. Southwest Chapter, Society of Nuclear Medicine and Molecular Imaging. Arlington, TX, US.
- 2018. Artifacts, Incidentals, and Pitfalls in PET/CT - Part 1: Whole Body, Head & Neck and Chest. Conference. Greater New York Chapter Society of Nuclear Medicine and Molecular Imaging. Atlantic City, NJ, US.
- 2017. PET/CT and Lymphoma: Evolution to New Criteria. Conference. Greater New York Chapter Society of Nuclear Medicine and Molecular Imaging. Atlantic City, NJ, US.
- 2016. PET/CT in Lymphoma: What the Clinicians Want to Know!. Conference. Society of Nuclear Medicine and Molecular Imaging. Dallas, TX, US.
- 2016. PET/CT in the Management of Breast Cancer: 2016 Update. Conference. Greater New York Chapter, Society of Nuclear Medicine and Molecular Imaging. Atlantic City, NJ, US.
- 2015. PET/CT in Lung and Esophageal Cancer. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2015. Parathyroid Imaging: Synergy in Multi-Modality Imaging. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2014. Blood and Guts, The Nuclear Medicine Bleeding Scan. Conference. Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2013. Nuclear Medicine in Breast Cancer: Evaluation of Regional and Distant Metastases. Conference. Southwestern Chapter, Society of Nuclear Medicine. Las Colinas, TX, US.
- 2013. PET/CT and Lymphoma: 2013 Update. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2012. PET Normal Variants and Common Incidental Findings. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2011. Physiologic & Benign Variants on FDG PET Imaging. Conference. Southwestern Chapter, SNM. Oklahoma City, OK, US.
- 2011. PET/CT in the Management of Breast Cancer. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2010. Lung Cancer & Esophageal Cancer: Fundamentals for PET/CT. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2009. Blood and Guts; The Nuclear Medicine Bleeding Scan, Greater New York Society of Nuclear Medicine Spring Symposium. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2008. PET/CT and Lymphoma: An Evolving Paradigm for Cancer Management. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2007. PET/CT for the Management of Lymphoma: A Physician's Viewpoint. Conference. Society of Nuclear Medicine. Stamford, CT, US.
- 2007. Acute GI Bleeding: A Nuclear Medicine Physician Viewpoint. Conference. Greater New York Chapter, Society of Nuclear Medicine. Atlantic City, NJ, US.
- 2007. Use of PET/CT in the Management of Lymphoma. Conference. Montefiore Medical Centre; Department of Nuclear Medicine Grand Rounds. Bronx, NY, US.
- 2006. CD20: From Molecule to Medical Therapy and Beyond. Conference. Montefiore Medical Centre; Department of Nuclear Medicine Grand Rounds. Bronx, NY, US.
- 2003. Heparin Induced Thrombocytopenia; Case Presentation. Conference. Yale New Haven Hospital; Internal Medicine Grand Rounds. New Haven, CT, US.
National Presentations
- 2021. Interesting PET Cases: Covid related, drug toxicity, and other pitfalls. Invited. IAEA Regional Training Course on Targeted Radionuclide Therapy. Houston, TX, US.
- 2021. FDG PET/CT and Lymphoma Response (in the COVID era). Invited. IAEA Regional Training Course on Targeted Radionuclide Therapy. Houston, TX, US.
- 2021. Evaluation of Response to Therapy with Special Focus on Lymphoma with FDG PET/CT. Invited. IAEA-Argonne Interregional Training Course on Theranostics including Quality of Practice. Houston, TX, US.
- 2021. Case Discussion Presentation. Invited. IAEA-Argonne Interregional Training Course on Theranostics including Quality of Practice. Houston, TX, US.
- 2019. FDG PET/CT and Lymphoma Response. Invited. IAEA Regional Training Course on Targeted Radionuclide Therapy. Houston, TX, US.
- 2018. Searching for the Parathyroid Adenoma: Synergy in Multi-Modality Imaging. Invited. Society of Nuclear Medicine. Philadelphia, PA, US.
- 2018. PET Imaging Response Criteria in Lymphoma. Invited. The Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2017. Nuclear Medicine Imaging of Neurodendocrine Tumors. Invited. Medical Education Program on Neurodendocrine Tumors. Houston, TX, US.
- 2016. Searching for the Parathyroid Adenoma: Synergy in Multi-Modality Imaging. Invited. Society of Nuclear Medicine and Molecular Imaging. San Diego, CA, US.
- 2011. Generating a Relevant Report: PET/CT and Lymphoma. Invited. 2011 Society of Nuclear Medicine. San Antonio, TX, US.
- 2011. Seeing What's on Your Mind: PET/CT Imaging of the Brain. Invited. 2011 Society of Nuclear Medicine. San Antonio, TX, US.
- 2011. Blood and Guts: The Nuclear Medicine Bleeding Scan. Invited. 2011 Society of Nuclear Medicine. San Antonio, TX, US.
- 2008. Blood and Guts, the Nuclear Medicine Bleeding Scan. Invited. SNM 2008 Annual Meeting. New Orleans, LA, US.
International Presentations
- 2018. Evaluation of response to therapy with special focus on lymphoma with FDG PET/CT. Invited. International Atomic Energy Agency. Houston, US.
- 2016. Evaluation of Response to Therapy: Focus on FDG PET and lymphoma. Invited. IAEA Regional Training Course on Targeted Radionuclide Therapy. Houston, US.
- 2014. Normal Variants and Pitfalls in PET/CT. Invited. Oncologic Diagnostic and Interventional Radiology CME. Bangalore, IN.
- 2014. PET/CT Imaging in Lymphoma, Lung Cancer and Esophagus. Invited. Oncologic Diagnostic and Interventional Radiology CME. Bangalore, IN.
- 2013. Searching for the Parathyroid Adenoma: Synergy in Multi-Modality Imaging. Invited. Society of Nuclear Medicine. Vancouver, BC, CA.
- 2013. Response Criteria in Solid Tumors and Bone Metastases: RECIST 1.1 and MDA. Invited. Society of Nuclear Medicine. Vancouver, BC, CA.
- 2012. Lymposcintigraphy and Sentinel Lymph Node Biopsy. Invited. 10th ABDA Teaching Course and Workshop 2012. Hong Kong, CN.
- 2012. Lymphoscintigraphy and Sentinel Lymph Node Biopsy. Invited. University of Texas MD Anderson Cancer Center Breast Cancer Symposium, and the 4th PUMCH Breast Disease Multidisciplinary Symposium. Beijing, CN.
- 2012. Radiologic Assessment of Therapy Response in Breast CA, Evaluation of Distant Metastases. Invited. 10th ABDA Teaching Course and Workshop 2012, Asian Breast Diseases Association. Hong Kong, CN.
- 2009. Seeing What's on Your Mind: PET/CT Imaging of the Brain. Invited. SNM 2009 Annual Meeting, CA.
Selected Publications
Peer-Reviewed Articles
- Kairemo K, Gouda M, Chuang HH, Macapinlac HA, Subbiah V. Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors. J Clin Med 13(11):3269, 2024. e-Pub 2024. PMID: 38892979.
- Kairemo, Kalevi, Gouda, Mohamed, Chuang, Hubert H, Macapinlac, Homer A, Subbiah, Vivek. Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine 13(11):3269, 2024. e-Pub 2024.
- Gouda MA, Zarzour MA, Vaporciyan AA, Kairemo K, Chuang HH, Subbiah V. Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma. Oncoscience 10:44-53, 2023. e-Pub 2023. PMID: 37736255.
- Nieto, Y, Gruschkus, SK, Valdez, B, Jones, R, Anderlini, P, Hosing, C, Popat, UR, Qazilbash, MH, Kebriaei, P, Alousi, AM, Saini, N, Srour, S, Rezvani, K, Ramdial, JL, Barnett, M, Gulbis, A, Shigle, TL, Ahmed, S, Iyer, SP, Lee, H, Nair, R, Parmar, S, Steiner, RE, Dabaja, BS, Pinnix, CC, Gunther, J, Cuglievan, B, Mahadeo, KM, Khazal, SJ, Chuang, HH, Champlin, RE, Shpall, E, Andersson, BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
- Cherng, HJ, Chuang, HH, Steiner, RE, Fayad, LE, Strati, P, Nair, R, Hagemeister, FB, Nastoupil, L, Lee, HJ, Neelapu, SS, Flowers, CR, Samaniego, F, Rodriguez, MA, Macapinlac, HA, Feng, L, Westin, JR. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. Leukemia and Lymphoma 63(1):74-83, 2022. e-Pub 2022. PMID: 34435552.
- Cherng HJ, Chuang HH, Steiner R, Fayad L, Strati P, Nair R, Hagemeister F, Nastoupil LJ, Lee HJ, Neelapu SS, Flowers CR, Samaniego F, Rodriguez M, Macapinlac HA, Feng L, Westin J. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. Leukemia and Ly, 2021. e-Pub 2021.
- Costelloe CM, Lin PP, Chuang HH, Amini B, Chainitikun S, Yu TK, Ueno NT, Murphy WA, Madewell JE. Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy. Semin Ultrasound CT MR 42(2):164-183, 2021. e-Pub 2021. PMID: 33814103.
- Fang H, Chuang HH, Strati P, Hu S, Shuai W, Medeiros LJ, Wang W. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic Findings. American Journal of Surgical Pathology 45(2):160-168, 2021. e-Pub 2021. PMID: 32769427.
- Chuang HH, Emery DJ, Campbell RM, Lu Y. FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms. Clin Nucl Med 45(8):656-658, 2020. e-Pub 2020. PMID: 32433162.
- Schmelz JL, Navsaria L, Goswamy R, Chuang HH, Miranda RN, Lee HJ. Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report. Br J Haematol. e-Pub 2019. PMID: 31721157.
- Cramer FM, Chuang HH, Miranda RN, Lee HJ. False-Positive Positron Emission Tomography After Combined-Modality Induction Therapy in a Patient With Newly Diagnosed Early-Stage Bulky Classic Hodgkin Lymphoma. J Oncol Pract 15(9):499-501, 2019. e-Pub 2019. PMID: 31310574.
- Wannachalee T, Turcu AF, Bancos I, Habra MA, Avram AM, Chuang HH, Waguespack SG, Auchus RJ. The Clinical Impact of [68 Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumors. Clin Endocrinol (Oxf) 91(2):288-294, 2019. e-Pub 2019. PMID: 31066920.
- Dai D, Chuang HH, Macapinlac HA, Li T, Pan T. Correlation of fluorine 18-labeled sodium fluoride uptake and arterial calcification on whole-body PET/CT in cancer patients. Nucl Med Commun 40(6):604-610, 2019. e-Pub 2019. PMID: 30688757.
- Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep 9(1):1322, 2019. e-Pub 2019. PMID: 30718585.
- Vu TH, Schellingerhout D, Guha-Thakurta N, Sun J, Wei W, Kappadth SC, Perrier N, Kim EE, Rohren E, Chuang HH, Wong FC. Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT CT and Multiphase Multidetector 4D CT. AJNR Am J Neuroradiol 40(1):142-149, 2019. e-Pub 2019. PMID: 30523145.
- Marcal LP, Patnana M, Yedururi S, Chuang HH, Devine CE, Cox V, Dasari A, Loyer E. Abdominal manifestations of neuroendocrine tumors. Digestive Disease Interventions 03(01):014-029, 2019. e-Pub 2019.
- Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2(11):1334-1343, 2018. e-Pub 2018. PMID: 29895624.
- Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy. Leukemia & Lymphoma(1042-8194), 2018. e-Pub 2018.
- Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2018. PMID: 29038339.
- Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS. Early-Stage Hodgkin Lymphoma Outcomes After Combined Modality Therapy According to the Post-Chemotherapy 5-Point Score:Can Residual PET-Positive Disease Be Cured with Radiotherapy Alone?. Br J Haematol 179(3):488-496, 2017. e-Pub 2017. PMID: 28832956.
- Christakis I, Vu T, Chuang HH, Fellman B, Figueroa AMS, Williams MD, Busaidy NL, Perrier ND. The diagnostic accuracy of neck ultrasound, 4D-Computed tomography and sestamibi imaging in parathyroid carcinoma. Eur J Radiol 95:82-88, 2017. e-Pub 2017. PMID: 28987702.
- Costelloe CM, Chuang HH, Daw NC. PET/CT of Osteosarcoma and Ewing Sarcoma. Semin Roentgenol 52(4):255-268, 2017. e-Pub 2017. PMID: 28965545.
- Subbiah V, Chuang HH, Gambhire D, Kairemo K. Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives. Diagnostics (Basel) 7(1), 2017. e-Pub 2017. PMID: 28212290.
- Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang HH, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2017. PMID: 28068241.
- Salem U, Amini B, Chuang HH, Daw NC, Wei W, Haygood TM, Madewell JE, Costelloe CM. 18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone. J Cancer 8(15):2892-2898, 2017. e-Pub 2017. PMID: 28928879.
- Pinnix CC, Shah JJ, Chuang HH, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, Fanale MA, Westin J, Nastoupil L, Hagemeister FB, Rodriguez A, Qazilbash M, Shah N, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja B. Doxorubicin-based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-8, 2016. e-Pub 2016. PMID: 26795083.
- Wang ML, Lee H, Chuang HH, Wagner-Bartak N, Hagemeister F, Westin J, Fayad L, Samaniego F, Turturro F, Oki Y, Chen W, Badillo M, Nomie K, Dela Rosa M, Zhao D, Lam L, Addison A, Zhang H, Young KH, Li S, Santos D, Medeiros LJ, Champlin R, Romaguera J, Zhang L. Ibritinib in combination with Rituximab in Relapsed or Refractory Mantle Cell Lymphoma: A Single-centre, Open-label, Phase 2 Trial. The Lancet Oncology, 2015. e-Pub 2015. PMID: 26640039.
- Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale MA, Nieto Y, Khouri IF, Ahmed S, Medeiros LJ, Davis RE, Westin J. Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated with Immunovchemotherapy in the Setting of Response Assessment by (18)fluorodeoxyglucose Positron Emission Tomography. Int J Radiat Oncol Biol Phys 1;92(1):113-21, 2015. e-Pub 2015. PMID: 25863759.
- Blonska M, Zhu Y, Chuang HH, You MJ, Kunkalla K, Vega F, Lin X. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment. Blood 125(6):981-91, 2015. e-Pub 2015. PMID: 25533033.
- Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL, Macapinlac HA, Chuang HH. Impact of (18)F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients. Eur J Nucl Med Mol Imaging 41(11):2066-73, 2014. e-Pub 2014. PMID: 24990404.
- Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, Wei W, Chuang HH. The value of (18)F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging 41(9):1756-66, 2014. e-Pub 2014. PMID: 24699907.
- Oki Y, Chuang HH, Chasen B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol 165(1):112-6, 2014. e-Pub 2014. PMID: 24386943.
- Amini B, Madewell JE, Chuang HH, Haygood TM, Hobbs BP, Fox PS, Bassett RL, Costelloe CM. Differentiation of Benign Fluid Collections from Soft-Tissue Sarcomas on FDG-PET/CT. J Cancer 5(5):328-35, 2014. e-Pub 2014. PMID: 24723975.
- Oki Y, Westin JR, Vega F, Chuang HH, Fowler N, Neelapu S, Hagemeister FB, McLaughlin P, Kwak LW, Romaguera JE, Fanale M, Younes A, Rodriguez MA, Orlowski RZ, Wang M, Ouzounian ST, Samaniego F, Fayad L. Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma. Br J Haematol 163(5):611-20, 2013. e-Pub 2013. PMID: 24117234.
- Dabaja BS, Phan J, Mawlawi O, Medeiros LJ, Etzel C, Liang FW, Podoloff D, Oki Y, Hagemeister FB, Chuang H, Fayad LE, Westin JR, Shihadeh F, Allen PK, Wogan CF, Rodriguez MA. Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma. Leuk Lymphoma 54(12):2631-8, 2013. e-Pub 2013. PMID: 23488661.
- Costelloe CM, Chuang HH, Chasen BA, Pan T, Fox PS, Bassett RL, Madewell JE. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT. J Cancer 4(7):524-30, 2013. e-Pub 2013. PMID: 23983816.
- Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: Trends and advances. World J Radiol 5(3):126-42, 2013. e-Pub 2013. PMID: 23671749.
- Chuang HH, Deniz F, Sircar K, Jimenez C, Rubin De Celis C, Wood CG, Habra MA. [18F]Fluorodeoxyglucose Positron Emission Tomography-Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case. J Clin Oncol 10(30 26):246-9, 2012. e-Pub 2012. PMID: 22649135.
- Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY. Positron Emission Tomography for Assessing Local Failure After Stereotactic Body radiotherapy for Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 83(5):1558-65, 2012. e-Pub 2012. PMID: 22572078.
- Younes A, Oki Y, McLaughlin P, Copeland AR, Goy A, Pro B, Feng L, Yuan Y, Chuang HH, Macapinlac HA, Hagemeister F, Romaguera J, Samaniego F, Fanale MA, Dabaja BS, Rodriguez MA, Dang N, Kwak LW, Neelapu SS, Fayad LE. Phase II Study of Rituximab Plus ABVD in Patients with Newly Diagnosed Classical Hodgkin Lymphoma. Blood 119(18):4123-8, 2012. e-Pub 2012. PMID: 22371887.
- Shkumat NA, Springer A, Walker CM, Rohren EM, Yang WT, Adrada BE, Arribas E, Carkaci S, Chuang HH, Santiago L, Mawlawi OR. Investigating the limit of detectability of a positron emission mammography device: a phantom study. Med Phys 38(9):5176-85, 2011. e-Pub 2011. PMID: 21978062.
- Shahani S, Ahmad A, Barakat FH, Chuang HH, Fowler NH, Myers JN, Stava C, Habra MA. F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma. Clin Nucl Med 36(4):317-9, 2011. e-Pub 2011. PMID: 21368613.
- Hulme KW, Rong J, Chasen B, Chuang HH, Cody DD, Wong FC, Kappadath SC. A CT Acquisition Technique to Generate Images at Various Dose Levels for Prospective Dose Reduction Studies. AJR Am J Roentgenol 196(2):W144 - W151, 2011. e-Pub 2011. PMID: 21257855.
- Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80-92, 2010. e-Pub 2010. PMID: 20842228.
- Habra MA, Núñez R, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C. Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging. Endocrine 37(1):209-12, 2010. e-Pub 2010. PMID: 20963572.
- Ayala-Ramirez M, Callender GG, Kupferman ME, Rich TA, Chuang HH, Trent J, Perrier ND, Goodarzi M, Jimenez C. Paraganglioma Syndrome Type 1 in a Patient With Carney-Stratakis Syndrome. Nat Rev Endocrinol 6(2):110-5, 2010. e-Pub 2010. PMID: 20098451.
- Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, Yokoyama WM. Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells. J Exp Med 191(8):1341-54, 2000. e-Pub 2000. PMID: 10770801.
Invited Articles
- Chuang HH, Macapinlac HA. The Evolving Role of PET-CT in the Management of Esophageal Cancer. Q J Nucl Med Mol Imaging 53(2):201-209, 2009. e-Pub 2009. PMID: 19293768.
Review Articles
- Al-Hadidi SA, Chuang HH, Miranda RN, Lee HJ. Programmed Cell Death One Inhibition Therapy in Classical Hodgkin Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 21(2):e105-e111, 2021. e-Pub 2021. PMID: 33160934.
- Perrier ND, Arnold A, Costa-Guda J, Busaidy NL, Nguyen H, Chuang HH, Brandi ML. New and future perspectives for parathyroid carcinoma. Endocr Relat Cancer 27(8):T53-T63, 2020. e-Pub 2020. PMID: 32449693.
- Zafereo M, Yu J, Angelos P, Brumund K, Chuang HH, Goldenberg D, Lango M, Perrier N, Randolph G, Shindo ML, Singer M, Smith R, Stack BC, Steward D, Terris DJ, Vu T, Yao M, Tufano RP. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398-2409, 2019. e-Pub 2019. PMID: 31002214.
- Rydzak C, Chauhan A, Gupta N, Chuang HH, Rohren EM, Bhosale PR. Fat-Containing Hypermetabolic Masses on FDG PET/CT: A Spectrum of Benign and Malignant Conditions. AJR Am J Roentgenol 207(5):1095-1104, 2016. e-Pub 2016. PMID: 27490138.
- Costelloe CM, Chuang HH, Madewell JE. FDG PET/CT of Primary Bone Tumors. AJR Am J Roentgenol 202(5):W521-31, 2014. e-Pub 2014. PMID: 24848845.
Other Articles
- Brown SJ, Waguespack SG, Chuang HH, Murphy WA, Hu MI Detecting the undetectable. Clinical Thyroidology 32(1), 2020.
- Costelloe CM, Chuang HH, Madewell JE FDG PET for the Detection of Bone Metastases: Sensitivity, Specificity, and Comparison with Other Imaging Modalities. PET Clin 5:281-295, 2010.
Abstracts
- Cherng HJ, Steiner R, Fayad L, Strati P, Nair R, Hagemeister F, Nastoupil L, L HJ, Neelapu S, Flowers C, Samaniego F, Rodriguez M, Feng L, Chuang H, Westin W. Persistent Overall Response on Early PET/CT Scans during Salvage Therapy for Relapsed or Refractory DLBCL Predicts for Disease Specific Survival. 62nd American Society of Hemtology Annual Meeting, San Diego, CA, 2020. e-Pub 2020.
- Brown SJ, Waguespack SG, Chuang CH, Murphy WA, Hu MI. Radiologic response by gallium dotatate PET/CT in patients with medullary thyroid carcinoma on systemic therapy. 89th Annual Meeting of the American Thyroid Association, 2019. e-Pub 2019.
- Westin JR, Nastoupil L, Fayad L, Hagemeister F, Young K, McDonnell T, Neelapu S, Davis RE, Green M, Ahmed S, Nair R, Steiner R, Lee H, Rodriguez M, Parmar S, Chuang H. Very early FDG PET/CT scan may predict outcomes in relapsed or refractory DLBCL patients treated wit salvage therapy. 15th International Conference on Malignant Lymphoma, 2019. e-Pub 2019.
- Westin, JR, Nastoupil L, Hagemeister F, Fayad L, Young K, McDonnel T, Chuang H, Ahmed S, Nair R, Steiner R, Lee H, Rodriguez M, Parmar S, Green M, Neelapu S, Davis R. Rituximab, lenalidomide, and ibrutinib alone prior to combination with chemotherapy for patients with newly diagnostid diffuse large B-cell lymphoma. 15th International Conference on Malignant Lymphoma, 2019. e-Pub 2019.
- Dai D, Chuang HH, Macapinlac HA, Li T, Pan T. Correlation of 18F-NaF uptake and calcification of the major blood vessels in the 18F-NaF PET/CT scans. 2018 SNNMI Annual Meeting, 2018. e-Pub 2018.
- Dai D, Chuang HH, Macapinlac HA, Pan T. Correlation of F18-sodium fluoride (NaF) uptake and the calcified plaques of the major blood vessels in NaF PET/CT. 2017 RSNA Annual Meeting, 2017. e-Pub 2017.
- Westin JR, Oki Y, Fayad L, Nastoupil LJ, Turturro F, Hagemeister FB, Sathyanarayanan V, Young KH, McDonnell T, Chuang HH, Zhou S, Neelapu SS, Davis RE. Rituximab, Lenalidomide, and Ibrutinib Alone and Combined with Dose Adjusted Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
- Sathyanarayanan V, Chihara D, Fanale MA, Costelloe CM, Ghonimi E, Shen C, Vega F, Dabaja BS, Oki Y, Zhou S, Chuang HH. Prognostic Value of PET-CT in Early Stage Hodgkin Lymphoma (HL) Using Updated 5 Point Scoring System. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
- Fanale M, Hagemeister FB, Fayad L, Oki Y, Fowler N, Romaguera J, Shah N, Chuang HH, Feng L, Horowitz SB, Wesson E, Hutto TY, Muzzafar T, Samaniego F, Davis RE. A Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas. 2014 ASH Annual Meeting, 2014. e-Pub 2014.
- Salem UI, Wei W, Madewell JE, Chuang HH, Amini B, Haygood TM, Costelloe C, Daw BN. 18F-FDG PET/CT as an Indicator of Survival in Bone Primary Ewing Sarcoma. RSNA 100th Scientific Assembly and Annual Meeting, 2014. e-Pub 2014.
- Wong FC, Schellingerhout D, Rohren E, Vu T, Kappadath CS, Wong S, Chuang HH, Kim E, Guha-Thakurta N, Perrier ND. Localization of Parathyroid Adenomas by Tc99m Sestamibi SPECT-CT, Contrast-enhanced Multi-phase CT (4D-CT) and Combination of SPECT-CT and 4D-CT. RSNA 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
- Behrang A, Madewell JE, Chuang HH, Haygood TM, Fox PS, Bassett RL, Costelloe CM. Differentiation of Benign Fluid Collections from Sarcomas on FDG-PET/CT. Texas Radiological Society 99th Annual Scientific Meeting, 2013. e-Pub 2013.
- Chauhan A, Chuang HH, Jeph S, Rohren EM, Bhosale PR. Fatty Hypermetabolic Masses on FDG PET-CT: A Spectrum of Benign and Malignant Conditions. RSNA 99th Scientific Assembly and Annual Meeting, 2013. e-Pub 2013.
- Takeuchi S, Balachandran A, Habra MA, Phan A, Macapinlac H, Chuang HH. 18F-FDG PET Use in the Management of Adrenocortical Carcinoma. 2013 Society of Nuclear Medicine & Molecular Imaging Annual Meeting, 2013. e-Pub 2013.
- Takeuchi S, Balachandran A, Habra MA, Phan A, Macapinlac HA, Chuang HH. 18F-FDG PET Use In Adrenocortical Carcinoma. SNMMI Annual Meeting, 2013. e-Pub 2013.
- Khiewvan B, Chelouche Lev D, McCutcheon IE, Slopis JM, Al Sannaa GA, Macapinlac H, Chuang HH. The Value and Therapeutic Impact of 18F-FDG PET/CT in Malignant Peripheral Nerve Sheath Tumors. 2013 Society of Nuclear Medicine & Molecular Imaging Annual Meeting, 2013. e-Pub 2013.
- Oki Y, Chuang HH, Chasen B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The Prognostic Value of Interim PET Scan in Patients with Classical Hodgkin Lymphoma. 2012 ASH Annual Meeting, 2012. e-Pub 2012. PMID: 24386943.
- Pan T, Zhang X, Riegel A, Chang J, Chuang HH. Compensation for partial volume effect in PET for treatment response assessment of stereotactic body radiotherapy. Annual Meeting of the Society of Nuclear Medicine, 2011. e-Pub 2011.
- Dabaja B, Phan J, Medeiros LJ, Hagemeister FB, Chuang HH, Fayad LE, Shihadeh F, Allen PK, Wogan C, Rodriguez A. Clinical implications of PET-negative residual disease at the completion of chemotherapy for diffuse large B-cell lymphoma. 47th Annual Meeting of the American Society of Clinical Oncology, 2011. e-Pub 2011.
- Wong F, Vu T, Duan X, Chuang HH, Schellingerhout D, Kappadath S, Johnson V, Rohren E, Perrier N, Kim EE. Comparison of ultrasonography, Tc-99m sestamibi SPECT-CT and contrast-CT in the localization of parathyroid adenoma. Society of Nuclear Medicine Annual Meeting, 2011. e-Pub 2011.
- Zhang X, Balter P, Pan T, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY. PET/CT and outcome in lung cancer treated with stereotactic body radiation therapy. ASTRO Annual Meeting. Int J Rad Onc Bio Phy 78(3):S16, 2010. e-Pub 2010.
- Chuang HH, Lodge MA, Wahl RL. Initial evaluation of respiratory gated PET/CT of upper abdominal lesions. Society of Nuclear Medicine Annual Meeting:108, 2008. e-Pub 2008.
- Chuang, HH. New and Future Perspectives for Parathyroid Carcinoma. Society for Endocrinology.
Book Chapters
- Bronstein Y, Overman MJ, Chuang HH, Raval B, Silverman PM. Small Bowel Malignant Tumors. In: Silverman Oncol Imaging 2e. Elvesier, 2022.
- Costelloe, CM, Lin PP, Chuang HH, Amini B, Ueno NT, Chainitukun S, Yu TK, Madewell JE. Bone Metastases. In: Silverman Oncol Imaging. Second. Elsevier, 2022.
- Marcal, LP, Chuang, HH, Tran Cao, HS, Halperin, DM. Pancreatic Neuroendocrine Tumors. In: Oncologic Imaging : a Multidisciplinary Approach. 2nd. Elsevier, 197-217, 2022.
- Chuang HH, Gradinscak D, Macapinlac HA. Malignancy of Unknown Origin. In: A Case-Based Approach to PET/CT in Oncology. Victor H. Gerbaudo, Editor, 2012.
- Fayad L, Konoplev S, Chuang HH, Rodriguez MA. Aggressive and Highly Aggressive B-Cell Lymphyomas. In: The MD Anderson Manual of Medical Oncology, 2011.
Books (edited and written)
- Costelloe, C, Valenzuela Perez, RF, Chuang, HH, Madewell, JE. Imaging of Bone Metastases. Springer, Cham, 2022.
- Costelloe, C, Lin, PP, Chuang, HH, Amini, B, Ueno, NT, Chainitikun, S, Kuan Yu, T, Madewell, JE. Bone Metastases. Ed(s) 2nd Edition. Elsevier, 2022.
Patient Reviews
CV information above last modified March 24, 2026